Clinical trial
A Phase I Safety and Immunogenicity Trial of Recombinant HIV-1 Tat Protein in HIV-1 Uninfected Adult Volunteers
NCT00529698 is registered in ClinicalTrials.gov with Istituto Superiore di Sanità as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Safety and Immunogenicity Trial of Recombinant HIV-1 Tat Protein in HIV-1 Uninfected Adult Volunteers
- Lead sponsor
- Istituto Superiore di Sanità
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2004
- Completion date
- November 30, 2007
- Enrollment
- 20 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.